Senior Director/Head of Investor Relations

Finance Cambridge, Massachusetts


Company Overview

Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.  The company is founded on the belief that the repertoire of T cell receptor (TCR)-antigen codes that drive health and disease represents one of the greatest opportunities for innovation in medical science.  Repertoire scientists created and developed the DECODE and DEPLOY suite of technologies, which allow in-depth characterization of TCR-antigen pairs, and the ability to rationally design and develop novel targeted immune medicines.

From its sites in Cambridge, Mass., and Zurich, Switzerland, Repertoire’s team of more than 120 is creating a new category of immune medicines enabled from its DECODE discovery platform.  The company’s first product in the clinic is a novel multiclonal T cell therapy consisting of T cells derived from the peripheral blood, activated against a curated set of antigens, and armed with a proprietary cytokine.  Repertoire is in clinical-stage immuno-oncology development today, targeting metastatic solid tumors.  In the field of autoimmunity, Repertoire is using its proprietary platform to discover novel epitopes and TCRs from patients with type 1 diabetes.  The company is also using its DECODE platform to discover infectious disease antigens and responding T cell clones.

Role Overview

The Head of Investor Relations will report to the Chief Financial Officer (CFO) and work closely with the executive team to establish and implement a successful investor relations strategy that articulates and supports the company's business and scientific objectives to the investment community and other external audiences.  The successful candidate will support communicating Repertoire’s corporate strategy, the competitive positioning, and quarterly financial results and outlook to institutional shareholders and other stakeholders.  The Head of Investor Relations, in conjunction with the Senior Director of Communications, will manage financial communications, with a primary focus on analysts and investors, and build new and manage existing relationships with the investment community and other outside influencers.

Key Responsibilities

  • Develop investors’ confidence and belief in the company’s vision and strategy for delivering shareholder value.
  • Develop the investor relations program to ensure a consistent, timely flow of information about Repertoire to the investment communities and company shareholders.
  • Partner with cross-functional teams to synthesize business intelligence including real-time insights and analysis of analyst research, investor sentiment, and competitor activity.
  • Effectively prepare executive leadership and other internal stakeholders for investor interactions.
  • Serves as the key point of contact for the investment community.
  • Partner with the CEO, CFO, and other executive officers to lead and manage Repertoire’s participation on quarterly earnings calls, investment conference calls and in-house meetings, road shows, analyst days, and one-on-one meetings.
  • Understand the science, technology, and business strategy sufficiently to identify issues and effectively communicate with investors.
  • Develop relationships and maintain regular communication with individual investors and covering analysts to provide up-to-date information about events and market trends affecting Repertoire with the goal of communicating the long-term vision.
  • In conjunction with the Senior Director of Corporate Communications, lead strategic communications development including developing communications plan to take advantage of key corporate milestones, preparing press releases, presentation decks and earnings releases, creating management Q&As, conference call scripts, and other information for securities filings.
  • Advise the executive team and board of directors regarding financial trends, shareholders concerns, and competitor actions that might impact the company.
  • Prepare SEC filings in collaboration with the CFO, General Counsel, and Finance team.
  • Establish strong internal relationships and effective communication with supporting business, scientific, and medical leadership within the organization.


  • Bachelor's degree required; MBA or Ph.D. preferred.
  • 10+ years of professional level experience with a minimum of 7 years of experience in investor relations, corporate communications, and related areas.
  • A minimum of 5 years of investor relations experience in the biotech/pharmaceutical industry, speaking and presenting to investors and analysts.
  • Experience in delivering clear consistent messaging of scientific and clinical concepts across multiple stakeholders/audiences.
  • Proven track record of developing a positive, long-term relationship with the investment community.
  • Able to communicate clearly and succinctly in a variety of communication settings and styles.
  • Experience with, and a working knowledge of, SEC disclosure requirements, shareholder/analyst communications practices, and preparing investor presentations and events.
  • Demonstrated experience to lead and influence within a matrixed environment including with senior management.
  • Experience in managing and overseeing contract IR/PR agencies and vendors.


Repertoire is committed towards social responsibility and developing an inclusive culture. Much as the power of the immune system lies in the diversity of T and B cells, our work requires the creativity and ingenuity of a diverse workforce.  We believe in actively pursuing equity in all facets of the work experience at Repertoire.  We will continue to educate ourselves about the inequities and barriers present in our society and take action as a company where we can make a difference.

Repertoire is proud to be an Equal Opportunity Employer.